This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...

Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...

WATERTOWN, Mass.--(BUSINESS WIRE)--RootPath announced today the US launch of its flagship product, RootPath Custom Gene Library. Similar to conventional gene synthesis products, this product is ...

EVONETIX LTD (‘Evonetix’), the Company developing semiconductor scale technology to improve access to gene synthesis, today announces the introduction of new branding to align with its vision to ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...

The International Gene Synthesis Consortium (IGSC), an organization of the world’s leading gene synthesis companies, continues to drive the advancement of biosecurity screening. A recent “red teaming” ...

Genetic medicines such as cell and gene therapies and mRNA vaccines offer extraordinary promise for treating a variety of diseases, including genetic disorders, cancer, and autoimmune diseases. These ...

Experienced senior executive brings proven track record in financial strategy, operational excellence, and commercial execution ...